The trajectory of companies tied to flagship drugs like Viagra presents a challenging investment landscape . While the initial surge of copyright, fueled by Viagra's unprecedented popularity, generated substantial wealth , the loss of exclusivity in key territories has introduced substantial volatility. Investors are now grappling with the impact o